Mr Denzil Benjamin, ICON: New guidelines by India's CDSCO will re-define the industry in 2013
Clinical Research | Opinion | By BioSpectrum Bureau | 0 Comment | 25 Dec, 2012
Adapting technology and tools to address the issues of increasing research and development (R&D) costs, slow results, lack of funding, regulatory requirements, multiple databases, and s...Read more
India strengthens clinical trial regulations
Clinical Research | Regulatory | By BioSpectrum Bureau | 0 Comment | 16 May, 2012
In a bid to strengthen the regulation and monitoring of clinical trials in the country, the Indian government has announced several measures. Union Minister for Health and Family Welfare Mr...Read more
PAREXEL inks services deal with Taiwan hospital
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 28 Nov, 2012
Singapore: Taiwan's PAREXEL International, a biopharmaceutical services provider, and National Taiwan University Hospital (NTUH) have collaborated to provide drug development services in Ta...Read more
Merger and Acquisition in CRO-Annual BSA CRO Survey
Clinical Research | Analysis | By Nandita Singh | 0 Comment | 11 Oct, 2015
According to business intelligence provider, GBI Research, total number of deals in the global contract research organization market reached 700 between January 2010 and April 2015, achievi...Read more
Fight between local and global CROs intensifies
Clinical Research | Influencers | By BioSpectrum Bureau | 0 Comment | 03 Sep, 2012
Mr Malcolm Burgess relocated to Hong Kong in 2011 to take up the role of executive vice president of ICON with special responsibility for the growth and development in Asia Pacific (APA C)....Read more
Malaysia to build on its clinical research potential
Clinical Research | Opinion | By BioSpectrum Bureau | 0 Comment | 05 Jun, 2012
Malaysia's aspiration is to be a developed nation by the year 2020. With 10 years more to prepare for this anticipated year, current Prime Minister Datuk Seri Mohd Najib Tun Razak announc...Read more
PPD acquires patient recruitment firm Acurian
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 28 Aug, 2013
Singapore: Pharmaceutical Product Development, (PPD) has acquired Acurian, a service provider of clinical trial patient enrollment and retention solutions for the life sciences industry. "A...Read more
Daiichi Sankyo extends Medidata Clinical Cloud use to China
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 07 Aug, 2013
Singapore: Daiichi Sankyo is expanding its use of US-based Medidata Solutions' cloud-based platform to support clinical trials conducted by its division in China. Daiichi Sankyo will bring ...Read more
CROs and BPOs give pharmacovigilance a new edge
Clinical Research | Opinion | By BioSpectrum Bureau | 0 Comment | 17 Sep, 2012
Demand in emerging markets is opening up newer opportunities across various sectors and life sciences companies have several compelling reasons to build their presence in these markets. Em...Read more
China: Emerging drug discovery destination
Clinical Research | Opinion | By BioSpectrum Bureau | 0 Comment | 13 Apr, 2012
China's growing economic strength and population of 1.3 billion people holds tremendous potential for global pharma and biotech companies as a location for clinical trials, as well as a mar...Read more
Linear Clinical Research wins Emerging Exporter Award
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2012
Singapore: Australian company Linear Clinical Research has won the Emerging Exporter of the year Award at the 50th annual Premier's Western Australian Export Awards. The awards aim to recog...Read more
India's CRO industry raises concerns at workshop
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 16 Jul, 2012
New Delhi: At a media workshop on the clinical research industry (CRO) held at Delhi on July 13, 2012, industry experts urged the media to report in a balanced way. The workshop attended by...Read more
Senz starts phase II cancer trial
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 10 Dec, 2012
Singapore: Senz Oncology announced that the ï¬rst patient has commenced treatment in a phase I/II clinical evaluation of VAL-1000 in patients with acute leukaemias (protocol SO-2012-1)...Read more
India suffers adverse effects of clinical research
Clinical Research | Analysis | By BioSpectrum Bureau | 0 Comment | 29 Aug, 2013
Everything does not seem to be well in the pharmaceutical industry of Asia's third largest economy - India. Although the largest democracy of the world, which boasts of a population of 1.27...Read more
Resverlogix initiates phase II diabetes trials
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 17 Oct, 2012
Singapore: Resverlogix has initiated an exploratory phase II clinical trial in patients with pre-diabetes mellitus to examine the effects of RVX-208 and ApoA-I production on glucose metabo...Read more
Marken gets 12-year license in China
Clinical Research | News | By BioSpectrum Bureau | 0 Comment | 05 Oct, 2012
Singapore: Global clinical supply chain solutions provider Marken has been granted a 12-year license to ship biological samples and drug product within China. Marken plans to continue its e...Read more
Which domain of clinical research do APAC CROs focus on?
Clinical Research | Analysis | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more
Good Clinical Practice-certified investigators ensure quality in Malaysia
Clinical Research | Opinion | By BioSpectrum Bureau | 0 Comment | 17 Sep, 2013
The clinical trials landscape in Malaysia is very easy to navigate. The Malaysian government has been actively promoting clinical trials and other facets of biomedical development for man...Read more